tiprankstipranks
Salona Global Medical Device (TSE:EVMT)
:EVMT
Canadian Market
Holding TSE:EVMT?
Track your performance easily

Salona Global Medical Device (EVMT) Earnings Dates, Call Summary & Reports

12 Followers

Earnings Data

Report Date
Apr 07, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Jan 29, 2020
|
% Change Since: -14.29%
|
Next Earnings Date:Jul 30, 2019
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with significant revenue growth and successful debt reduction. The company's strategic initiatives, such as the white labeling strategy, are expected to drive future growth without additional capital requirements. However, challenges remain with capital-intensive product lines and existing debt obligations.
Company Guidance
During the Q2 2024 earnings call for Evome Medical Technologies, key financial metrics were highlighted, showcasing a significant turnaround for the company. Evome generated $10.5 million in revenue, with the core Biodex Rehab business contributing $6.1 million, marking a 59% increase from Q1 2024. Gross profits reached $3.3 million, with a notable 104% growth in the core business. The company also achieved a positive adjusted EBITDA of $421,000, an improvement of $1.7 million over the previous quarter. Debt reduction efforts were substantial, with a $2.7 million decrease in the quarter, including $2.6 million in acquisition debt and $200,000 from the credit line. Additional reductions included a $900,000 credit line payment in July and a targeted $185,000 payment in August. The company's strategy involves leveraging the Biodex brand for new product lines through white labeling, aiming for revenue growth without additional capital expenditure. The anticipated sale of DaMar Plastics is expected to eliminate $15.1 million in acquisition debt by June 2025, further stabilizing Evome's financial position.
Revenue Growth in Core Business
Evome generated $10.5 million in revenue for Q2 2024, with $6.1 million from the core business, Biodex Rehab. This represents a 59% revenue growth compared to Q1 2024.
Positive Adjusted EBITDA
Evome posted a positive adjusted EBITDA of $421,000 in Q2 2024, marking an improvement of $1.7 million over Q1 2024 and $1.4 million year-over-year compared to Q2 2023.
Debt Reduction
Evome reduced its debt by $2.7 million in Q2 2024, including $2.6 million from acquisition debt and $200,000 from the company's credit line. An additional reduction of $900,000 to the credit line was paid down in July 2024.
Strong Cash Position
Evome ended Q2 2024 with over $1 million in cash on hand, indicating improved liquidity compared to previous quarters.
White Labeling Strategy for Growth
Evome plans to expand the Biodex brand through a white labeling strategy, enabling it to offer new products without significant capital expenditure, which is expected to generate additional revenue in 2025.
---

Salona Global Medical Device (TSE:EVMT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:EVMT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 20192020 (Q1)
- / <0.01
-0.007214.29% (+0.01)
Jan 29, 20202020 (Q3)
- / <0.01
0.004-50.00% (>-0.01)
Jul 31, 20202020 (Q4)
- / >-0.01
0.008-175.00% (-0.01)
Jul 31, 20202021 (Q1)
- / -
0.008
Oct 31, 20202021 (Q2)
- / >-0.01
-0.004-100.00% (>-0.01)
Jan 21, 20212021 (Q3)
- / -0.01
0.002-650.00% (-0.01)
Jun 25, 20212021 (Q4)
- / -0.02
-0.006-200.00% (-0.01)
Jul 14, 20212022 (Q1)
- / -
-0.006
Oct 14, 20212022 (Q2)
-0.02 / -0.02
-0.008-200.00% (-0.02)
Jan 13, 20222022 (Q3)
- / -0.03
-0.011-172.73% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TSE:EVMT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 25, 2024C$0.14C$0.12-14.29%
Aug 12, 2024C$0.09C$0.12+33.33%
May 14, 2024C$0.20C$0.19-5.00%
Apr 01, 2024C$0.22C$0.220.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Salona Global Medical Device (TSE:EVMT) report earnings?
Salona Global Medical Device (TSE:EVMT) is schdueled to report earning on Apr 07, 2025, TBA Not Confirmed.
    What is Salona Global Medical Device (TSE:EVMT) earnings time?
    Salona Global Medical Device (TSE:EVMT) earnings time is at Apr 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:EVMT EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis